BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1156 related articles for article (PubMed ID: 28835262)

  • 41. Malaria case clinical profiles and Plasmodium falciparum parasite genetic diversity: a cross sectional survey at two sites of different malaria transmission intensities in Rwanda.
    Kateera F; Nsobya SL; Tukwasibwe S; Mens PF; Hakizimana E; Grobusch MP; Mutesa L; Kumar N; van Vugt M
    Malar J; 2016 Apr; 15():237. PubMed ID: 27113354
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of the quality and quantity of naturally induced antibody responses to EBA175RIII-V in Ghanaian children living in two communities with varying malaria transmission patterns.
    Abagna HB; Acquah FK; Okonu R; Aryee NA; Theisen M; Amoah LE
    Malar J; 2018 Jan; 17(1):14. PubMed ID: 29310662
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Diversity, Multiplicity of Infection and Population Structure of
    Abukari Z; Okonu R; Nyarko SB; Lo AC; Dieng CC; Salifu SP; Gyan BA; Lo E; Amoah LE
    Genes (Basel); 2019 Jun; 10(6):. PubMed ID: 31181699
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Naturally acquired immune responses to malaria vaccine candidate antigens MSP3 and GLURP in Guahibo and Piaroa indigenous communities of the Venezuelan Amazon.
    Baumann A; Magris MM; Urbaez ML; Vivas-Martinez S; Durán R; Nieves T; Esen M; Mordmüller BG; Theisen M; Avilan L; Metzger WG
    Malar J; 2012 Feb; 11():46. PubMed ID: 22335967
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetic diversity of the msp-1, msp-2, and glurp genes of Plasmodium falciparum isolates in Northwest Ethiopia.
    Mohammed H; Kassa M; Mekete K; Assefa A; Taye G; Commons RJ
    Malar J; 2018 Oct; 17(1):386. PubMed ID: 30359280
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunization of Saimiri sciureus monkeys with a recombinant hybrid protein derived from the Plasmodium falciparum antigen glutamate-rich protein and merozoite surface protein 3 can induce partial protection with Freund and Montanide ISA720 adjuvants.
    Carvalho LJ; Alves FA; Bianco C; Oliveira SG; Zanini GM; Soe S; Druilhe P; Theisen M; Muniz JA; Daniel-Ribeiro CT
    Clin Diagn Lab Immunol; 2005 Feb; 12(2):242-8. PubMed ID: 15699417
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetic diversity and allelic frequency of antigenic markers in Plasmodium falciparum isolates from Nnewi district in Nigeria.
    Ikegbunam MN; Anagu LO; Duru C; Nworu CS; Esimone CO; Ojurongbe O
    J Infect Dev Ctries; 2022 Mar; 16(3):557-563. PubMed ID: 35404863
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Plasmodium falciparum MSP3 Exists in a Complex on the Merozoite Surface and Generates Antibody Response during Natural Infection.
    Deshmukh A; Chourasia BK; Mehrotra S; Kana IH; Paul G; Panda A; Kaur I; Singh SK; Rathore S; Das A; Gupta P; Kalamuddin M; Gakhar SK; Mohmmed A; Theisen M; Malhotra P
    Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29760216
    [No Abstract]   [Full Text] [Related]  

  • 49. Pre-clinical assessment of novel multivalent MSP3 malaria vaccine constructs.
    Bang G; Prieur E; Roussilhon C; Druilhe P
    PLoS One; 2011; 6(12):e28165. PubMed ID: 22145028
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Optimization and validation of multi-coloured capillary electrophoresis for genotyping of Plasmodium falciparum merozoite surface proteins (msp1 and 2).
    Liljander A; Wiklund L; Falk N; Kweku M; Mårtensson A; Felger I; Färnert A
    Malar J; 2009 Apr; 8():78. PubMed ID: 19386138
    [TBL] [Abstract][Full Text] [Related]  

  • 51.
    Kusi KA; Amoah LE; Acquah FK; Ennuson NA; Frempong AF; Ofori EA; Akyea-Mensah K; Kyei-Baafour E; Osei F; Frimpong A; Singh SK; Theisen M; Remarque EJ; Faber BW; Belmonte M; Ganeshan H; Huang J; Villasante E; Sedegah M
    Front Cell Infect Microbiol; 2024; 14():1375249. PubMed ID: 38808064
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acquisition of antibodies to merozoite surface protein 3 among residents of Korogwe, north eastern Tanzania.
    Segeja MD; Mmbando BP; Seth MD; Lusingu JP; Lemnge MM
    BMC Infect Dis; 2010 Mar; 10():55. PubMed ID: 20205959
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acquired antibodies to merozoite antigens in children from Uganda with uncomplicated or severe Plasmodium falciparum malaria.
    Ahmed Ismail H; Ribacke U; Reiling L; Normark J; Egwang T; Kironde F; Beeson JG; Wahlgren M; Persson KE
    Clin Vaccine Immunol; 2013 Aug; 20(8):1170-80. PubMed ID: 23740926
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children.
    Dodoo D; Aikins A; Kusi KA; Lamptey H; Remarque E; Milligan P; Bosomprah S; Chilengi R; Osei YD; Akanmori BD; Theisen M
    Malar J; 2008 Jul; 7():142. PubMed ID: 18664257
    [TBL] [Abstract][Full Text] [Related]  

  • 55. DNA recovery from used malaria RDT to detect Plasmodium species and to assess Plasmodium falciparum genetic diversity: a pilot study in Madagascar.
    Andrianaranjaka VHI; Ravaoarisoa E; Rakotomanga TA; Ralinoro F; Rakoto DAD; Randrianarivo RH; Jeannoda V; Ratsimbasoa A
    Malar J; 2022 Jul; 21(1):227. PubMed ID: 35883089
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Naturally acquired antibody response to a Plasmodium falciparum chimeric vaccine candidate GMZ2.6c and its components (MSP-3, GLURP, and Pfs48/45) in individuals living in Brazilian malaria-endemic areas.
    Baptista BO; de Souza ABL; Riccio EKP; Bianco-Junior C; Totino PRR; Martins da Silva JH; Theisen M; Singh SK; Amoah LE; Ribeiro-Alves M; Souza RM; Lima-Junior JC; Daniel-Ribeiro CT; Pratt-Riccio LR
    Malar J; 2022 Jan; 21(1):6. PubMed ID: 34983540
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasmodium falciparum merozoite surface protein 1 (MSP1): genotyping and humoral responses to allele-specific variants.
    Ekala MT; Jouin H; Lekoulou F; Issifou S; Mercereau-Puijalon O; Ntoumi F
    Acta Trop; 2002 Jan; 81(1):33-46. PubMed ID: 11755430
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity.
    Singh S; Miura K; Zhou H; Muratova O; Keegan B; Miles A; Martin LB; Saul AJ; Miller LH; Long CA
    Infect Immun; 2006 Aug; 74(8):4573-80. PubMed ID: 16861644
    [TBL] [Abstract][Full Text] [Related]  

  • 59. msp1, msp2, and glurp genotyping to differentiate Plasmodium falciparum recrudescence from reinfections during prevention of reestablishment phase, Sri Lanka, 2014-2019.
    Gunasekera KT; Premaratne RG; Handunnetti SM; Weerasena J; Premawansa S; Fernando DS
    Malar J; 2024 Jan; 23(1):35. PubMed ID: 38281044
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular surveillance and temporal monitoring of malaria parasites in focal Vietnamese provinces.
    Van Long B; Allen G; Brauny M; Linh LTK; Pallerla SR; Huyen TTT; Van Tong H; Toan NL; Quyet D; Son HA; Velavan TP
    Malar J; 2020 Dec; 19(1):458. PubMed ID: 33384023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 58.